The databook is designed to serve as a comprehensive guide to navigating this
sector. The databook focuses on market statistics denoted in the form of
revenue and y-o-y growth and CAGR across the globe and regions. A detailed
competitive and opportunity analyses related to pharmacovigilance and drug safety software market will
help companies and investors design strategic landscapes.
on-demand was the
largest segment with a revenue share of
55.75% in
2023.
Horizon Databook has segmented the Global pharmacovigilance and drug safety software market based on on-premise, on-demand covering the revenue growth of each sub-segment from 2018 to
2030.
- Global Pharmacovigilance And Drug Safety Software Delivery Mode Outlook (Revenue, USD Million, 2018-2030)
- Global Pharmacovigilance And Drug Safety Software End Use Outlook (Revenue, USD Million, 2018-2030)
- Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
- CROs/BPOs or PV service providers when outsourced
- Others
- Global Pharmacovigilance And Drug Safety Software Functionality Outlook (Revenue, USD Million, 2018-2030)
- Case data collection and management
- Adverse event reporting and analysis
- Signal detection and other safety risk assessment
Reasons to
subscribe to Global pharmacovigilance and drug safety software market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of
Global pharmacovigilance and drug safety software market databook
-
Our clientele includes a mix of pharmacovigilance and drug safety software market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed
overview of
global-level
data and insights on the Global pharmacovigilance and drug safety software market , including
forecasts for subscribers. This
global
databook contains high-level insights into
Global pharmacovigilance and drug safety software market from
2018 to
2030, including revenue
numbers, major trends, and company profiles.